search
Back to results

Cerebral Oximetry in Cardiac Surgery to Reduce Neurological Impairment and Hospital Length-of-stay

Primary Purpose

Cardiac Surgery, Neural Injury, Cerebral Ischemia

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Physiological
Sponsored by
Hull University Teaching Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiac Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients undergoing elective cardiac surgery using cardiopulmonary bypass. Patient over 18 years age. -

Exclusion Criteria:

Emergency surgery. Cardiac surgery without cardiopulmonary bypass. Inability to perform test.

Persistent neurological conditions:

Recent stroke. Dementia. Alzheimer's Disease Parkinson's Disease

-

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    No Intervention

    Arm Label

    NIRS group. Brain oxygen saturations group.

    Standard Patient Monitoring

    Arm Description

    A monitor by means of non-invasive stickers will display cerebral oximetry (brain oxygen saturations) throughout the heart surgery.This gives a direct reading of brain frontal lobe oxygen levels. The baseline is recorded before the patient goes to sleep (anaesthetised) and throughout the surgery and time on cardiopulmonary bypass if the brain oxygen levels fall below baseline then various physiological changes are made to restore oxygen to baseline.

    No cerebral monitoring. Standard patient monitoring according to normal practice at Castle Hill Hospital apply.

    Outcomes

    Primary Outcome Measures

    Hospital length-of-stay
    How long before discharge post-operatively.
    Physical neurological examination
    Mobility and conscious control of limbs.
    Neurological assessment.
    Telephone interview to assess patients perception of mobility, function and well being. (see below details)
    Neurocognitive test 1
    Fluency and cognitive functions: Mini-Mental State Examination (MMSE). This test is conducted as a questionnaire of 11 questions. Questions include 'what is the date?', 'name the town you are in?', spelling-forwards and backwards, counting backwards, copying a picture, follow an instruction, naming objects etc. The test is scored out of 30 and recorded in a table. The test is repeated on the third post op day and the 2 scores compared to give a number which relates to performance.
    Neurocognitive Test 2
    Visual attention and task switching: Trail Making test A and B
    Neurocognitive test 3
    Visual-spatial, frontal lobe: Anti-saccadic eye test
    Neurocognitive test 4
    Executive function/verbal immediate and delayed recall: Hopkins Verbal and Hopkins Delay.
    Neurocognitive test 5
    General well-being HADS (hospital anxiety and depression score) A and D. HADS A -hospital anxiety and depression score relating to Anxiety. HADS D- hospital anxiety and depression score relating to Depression. Patients are asked a question and their response is scored from 0-3. There are 14 questions the score is recorded and compared with the score after the same questions on the 3rd post-op day. The result gives an indication of the patient's mental state and how it may have changed dur to the sugery.
    Late neurocognitive test 1.Telephone questionnaire using elements of the previously used questionnaires.
    General health questions were: how is your overall health, memory, mood, motor function?Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
    Late neurocognitive test 2. Telephone questionnaire using elements of the previously used questionnaires.
    Cognition questions were: Date, repeat and recall, serial 7s, spell, recall. Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
    Late neurocognitive test 3
    Functionality questions were: Stairs, driving, cleaning, dressing, eating/cooking.

    Secondary Outcome Measures

    Intensive Care length-of-stay
    Days on ICU. The time from the day of surgery to the discharge to the ward or death. assessed .
    Major organ dysfunction
    Renal function is assessed measuring creatinine. Gastrointestinal function is assessed by the diagnosis of ileus or ischaemic bowel at laparotomy. Cardiac function is assessed by the requirement for inotropic support. Respiratory function is assessed by the requirement for ventilation. All these outcomes are have clinical relevance during the stay on ICU.
    Mortality
    Death in hospital at any time following surgery. Death is considered a mortality.

    Full Information

    First Posted
    June 20, 2020
    Last Updated
    July 3, 2020
    Sponsor
    Hull University Teaching Hospitals NHS Trust
    Collaborators
    The Hull and East Riding Cardiac Trust Fund
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04463563
    Brief Title
    Cerebral Oximetry in Cardiac Surgery to Reduce Neurological Impairment and Hospital Length-of-stay
    Official Title
    Cerebral Oximetry in Adult Cardiac Surgery to Reduce the Incidence of Neurological Impairment and Hospital Length-of-stay: A Prospective, Randomized, Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    February 1, 2011 (Actual)
    Primary Completion Date
    March 1, 2014 (Actual)
    Study Completion Date
    September 1, 2014 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Hull University Teaching Hospitals NHS Trust
    Collaborators
    The Hull and East Riding Cardiac Trust Fund

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Cerebral oximetry using near-infrared spectroscopy (NIRS) has been shown to reduce the incidence of neurological dysfunction and hospital length-of-stay in adult cardiac surgery though not all studies agree. A previous audit using cerebral saturations at or above baseline showed improved neurological and length-of-stay outcomes.
    Detailed Description
    This prospective, single centre, double-blinded controlled study randomized 182 consecutive patients, scheduled for cardiac surgical procedures using cardiopulmonary bypass. Participants were randomized by concealed envelope prior to anaesthesia. NIRS study group were managed perioperatively using our NIRS protocol. The control group had standard management without NIRS. Primary outcomes were post-operative neurological impairment and hospital length-of-stay. Secondary outcomes included ventilation times, intensive care unit length-of-stay, major organ dysfunction and mortality

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiac Surgery, Neural Injury, Cerebral Ischemia

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    This prospective, single centre, double-blinded controlled study randomized 182 consecutive patients, scheduled for cardiac surgical procedures using cardiopulmonary bypass. Participants were randomized by concealed envelope.
    Masking
    ParticipantOutcomes Assessor
    Masking Description
    The personnel assessing and collecting the post-operative data were unaware of the patient group in the operating room.
    Allocation
    Randomized
    Enrollment
    182 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    NIRS group. Brain oxygen saturations group.
    Arm Type
    Active Comparator
    Arm Description
    A monitor by means of non-invasive stickers will display cerebral oximetry (brain oxygen saturations) throughout the heart surgery.This gives a direct reading of brain frontal lobe oxygen levels. The baseline is recorded before the patient goes to sleep (anaesthetised) and throughout the surgery and time on cardiopulmonary bypass if the brain oxygen levels fall below baseline then various physiological changes are made to restore oxygen to baseline.
    Arm Title
    Standard Patient Monitoring
    Arm Type
    No Intervention
    Arm Description
    No cerebral monitoring. Standard patient monitoring according to normal practice at Castle Hill Hospital apply.
    Intervention Type
    Other
    Intervention Name(s)
    Physiological
    Intervention Description
    Changes to carbon dioxide, oxygen flow, cardiac output, blood pressure, haemoglobin, surgical surveillance, depth of anaesthesia, patient position.
    Primary Outcome Measure Information:
    Title
    Hospital length-of-stay
    Description
    How long before discharge post-operatively.
    Time Frame
    Measured in days from the day of operation to the day the patient is discharged from hospital or death in hospital. If neither has occurred within 6 months of participant's operation it will be recorded as 6 months hospital stay.
    Title
    Physical neurological examination
    Description
    Mobility and conscious control of limbs.
    Time Frame
    3 day post-operatively
    Title
    Neurological assessment.
    Description
    Telephone interview to assess patients perception of mobility, function and well being. (see below details)
    Time Frame
    6 months post-operatively
    Title
    Neurocognitive test 1
    Description
    Fluency and cognitive functions: Mini-Mental State Examination (MMSE). This test is conducted as a questionnaire of 11 questions. Questions include 'what is the date?', 'name the town you are in?', spelling-forwards and backwards, counting backwards, copying a picture, follow an instruction, naming objects etc. The test is scored out of 30 and recorded in a table. The test is repeated on the third post op day and the 2 scores compared to give a number which relates to performance.
    Time Frame
    Day 3 post op.
    Title
    Neurocognitive Test 2
    Description
    Visual attention and task switching: Trail Making test A and B
    Time Frame
    Day 3 post op
    Title
    Neurocognitive test 3
    Description
    Visual-spatial, frontal lobe: Anti-saccadic eye test
    Time Frame
    Day 3 post op
    Title
    Neurocognitive test 4
    Description
    Executive function/verbal immediate and delayed recall: Hopkins Verbal and Hopkins Delay.
    Time Frame
    Day 3 post op
    Title
    Neurocognitive test 5
    Description
    General well-being HADS (hospital anxiety and depression score) A and D. HADS A -hospital anxiety and depression score relating to Anxiety. HADS D- hospital anxiety and depression score relating to Depression. Patients are asked a question and their response is scored from 0-3. There are 14 questions the score is recorded and compared with the score after the same questions on the 3rd post-op day. The result gives an indication of the patient's mental state and how it may have changed dur to the sugery.
    Time Frame
    Day 3 post op
    Title
    Late neurocognitive test 1.Telephone questionnaire using elements of the previously used questionnaires.
    Description
    General health questions were: how is your overall health, memory, mood, motor function?Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
    Time Frame
    6 months post op
    Title
    Late neurocognitive test 2. Telephone questionnaire using elements of the previously used questionnaires.
    Description
    Cognition questions were: Date, repeat and recall, serial 7s, spell, recall. Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
    Time Frame
    6 months post op
    Title
    Late neurocognitive test 3
    Description
    Functionality questions were: Stairs, driving, cleaning, dressing, eating/cooking.
    Time Frame
    6 months post op
    Secondary Outcome Measure Information:
    Title
    Intensive Care length-of-stay
    Description
    Days on ICU. The time from the day of surgery to the discharge to the ward or death. assessed .
    Time Frame
    The assessment period is every day on ICU until participant moved to ward. Or patient dies on ICU. Total assessment period 6 months.
    Title
    Major organ dysfunction
    Description
    Renal function is assessed measuring creatinine. Gastrointestinal function is assessed by the diagnosis of ileus or ischaemic bowel at laparotomy. Cardiac function is assessed by the requirement for inotropic support. Respiratory function is assessed by the requirement for ventilation. All these outcomes are have clinical relevance during the stay on ICU.
    Time Frame
    Before hospital discharge
    Title
    Mortality
    Description
    Death in hospital at any time following surgery. Death is considered a mortality.
    Time Frame
    Day of surgery to death. If the participant is discharged from hospital alive it is not a mortality. Assessed for 6 months from the day of surgery.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients undergoing elective cardiac surgery using cardiopulmonary bypass. Patient over 18 years age. - Exclusion Criteria: Emergency surgery. Cardiac surgery without cardiopulmonary bypass. Inability to perform test. Persistent neurological conditions: Recent stroke. Dementia. Alzheimer's Disease Parkinson's Disease -
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sean R Bennett, MB Chb
    Organizational Affiliation
    Consultant Anaesthetist Hull Hospital Trust
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Cerebral Oximetry in Cardiac Surgery to Reduce Neurological Impairment and Hospital Length-of-stay

    We'll reach out to this number within 24 hrs